Risks and benefits of calcium antagonists
Collins, R.; Peto, R.
Lancet 346(8980): 961-962
1995
ISSN/ISBN: 0140-6736 PMID: 7564740 Document Number: 447754
Document emailed within 1 workday
Related Documents
Tryba, M. 1988: Benefits and risks of H2 antagonists in anesthesia and intensive medicine Der Anaesthesist 37(11): 661-663Drozd, M.; Witte, K. 2013: Calcium supplementation in healthy subjects: benefits and risks Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 30(4)
Schoenberger, J.A. 1988: Calcium antagonists: use in hypertension evaluation of calcium antagonists in combination with diuretics Angiology 39(1 Part 2): 87-93
Shi, C.Z.; Li, X.M.; Liu, Y.; Zhang, J.T. 1990: Application of mouse tail artery for the study of alpha adrenoceptor agonists and antagonists and calcium antagonists Yao Xue Xue Bao 25(3): 223-226
Nishi, K.; Akaike, N.; Oyama, Y.; Ito, H. 1983: Actions of calcium antagonists on calcium currents in Helix neurons. Specificity and potency Circulation Research 52(2 Part 2): I53-I59
Van Zwieten, P.A. 1985: Calcium antagonists, calcium entry blockers and calcium overload blockers; nomenclature and classification Nederlands Tijdschrift Voor Geneeskunde 129(17): 777-780
Fleckenstein-Grün, G.; Frey, M.; Thimm, F.; Luley, C.; Czirfusz, A.; Fleckenstein, A. 1991: Differentiation between calcium- and cholesterol-dominated types of arteriosclerotic lesions: antiarteriosclerotic aspects of calcium antagonists Journal of Cardiovascular Pharmacology 18(Suppl 6): S1-S9
Gelmers, H.J. 1988: The significance of calcium in ischemic cell damage and the role of calcium antagonists in the treatment of acute cerebral ischemia Nederlands Tijdschrift Voor Geneeskunde 132(49): 2230-2232
Drábková, E.; Lazarová, Z.; Edelsteinová, S.; Czirfusz, A.; Gratzlová, J.; Holub, P. 1992: The effect of calcium antagonists on total calcium and magnesium levels in the aorta of rabbits after administration of dietary cholesterol Casopis Lekaru Ceskych 131(5): 146-148
Raddino, R.; Poli, E.; Pelà, G.; Ferrari, A.; Ghirarduzzi, A.; Ferrari, R. 1987: Effects of calcium antagonists on intracellular calcium deposits Cardiologia 32(4): 395-399
Beketov, A.I.; Gromova, T.M. 1988: Calcium, calcium antagonists and cerebral circulation Farmakologiia i Toksikologiia 51(2): 103-107
Van Zwieten, P.A.; van Meel, J.C.; Timmermans, P.B. 1982: Calcium antagonists and alpha 2-adrenoceptors: possible role of extracellular calcium ions in alpha 2-adrenoceptor-mediated vasoconstriction Journal of Cardiovascular Pharmacology 4(Suppl 3): S273-S279
Schomburg, L.; Koehrle, J. 2007: Selenium: benefits and risks MMW Fortschritte der Medizin 149(8): 34-36
Frankman, O. 1979: Risks and benefits of various contraceptive methods Nordisk Medicin 94(12): 307-311
Wyatt, H.V. 1978: Polio immunization: benefits and risks Journal of Family Practice 7(3): 469-474
Axelsson, I. 1981: Analysis of risks, costs and benefits Health Physics 40(2): 255-257
Saraghi, M.; Badner, V.M.; Golden, L.R.; Hersh, E.V. 2013: Propofol: an overview of its risks and benefits Compendium of Continuing Education in Dentistry 34(4): 252-258
Doyle, V.B. 1995: AZT in pregnant women with HIV: risks and benefits Neonatal Network: Nn 14(2): 62-63
Mofenson, H.C.; Caraccio, T.R. 1986: Benefits/risks of syrup of ipecac Pediatrics 77(4): 551-552
Hassed, C. 1999: The risks and benefits of complementary medicine Australian Family Physician 28(7): 732-733